醛基的反应活性：醛基具有一定的反应活性，可以与含氨基的化合物发生缩合反应等，这种反应特性使得CHO-Ph-PEG-COOH能够作为生物偶联剂，连接不同的生物分子，如蛋白质、抗体、酶等。

Mirum Pharma's Ctexli has become the first FDA-approved therapy for cerebrotendinous xanthomatosis (CTX), an ultra-rare form ...

Mirum Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CTEXLItm (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous ...

We recently published a list of These 10 Companies Led Tuesday’s Charge. In this article, we are going to take a look at ...

Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of metabolic syndrome and is the most common chronic liver disease in the world. The pathogenesis of NAFLD has not been fully ...

Inflammatory bowel disease (IBD) is a chronic immune-mediated inflammatory disorder of the gastrointestinal tract that arises due to complex interactions between host genetic risk factors, ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

Mannose-PEG-RGD 是一种生物偶联化合物，由甘露糖（Mannose）、聚乙二醇（PEG）和精氨酸-甘氨酸-天冬氨酸（RGD）多肽序列组成。这种结构融合了甘露糖的靶向性、PEG 的生物相容性和稳定性以及 RGD 多肽的细胞黏附特性。 【结构特点】： 甘露糖（Mannose）：具有与细胞 ...

were similar in wild-type and ACAT2-deficient mice fed a chow diet and were suppressed in both groups of mice fed the HF/HC diet (data not shown), which contains cholic acid, an inhibitor of genes ...